Argenx
ARGX
#488
Rank
HK$399.99 B
Marketcap
HK$6,400
Share price
0.52%
Change (1 day)
46.46%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): HK$123.35

According to Argenx 's latest financial reports the company's current EPS (TTM) is HK$123.78. In 2024 the company made an earnings per share (EPS) of HK$108.98 an increase over its 2023 EPS that were of -HK$40.40.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$123.35
2024HK$108.98-369.77%
2023-HK$40.40-60.46%
2022-HK$102.1763.33%
2021-HK$62.56-40.37%
2020-HK$104.91183.47%
2019-HK$37.01123.09%
2018-HK$16.5954.93%
2017-HK$10.7114.07%
2016-HK$9.3913.05%
2015-HK$8.30-36.34%
2014-HK$13.04209.04%
2013-HK$4.22-33.99%
2012-HK$6.39185.59%
2011-HK$2.24